SEC Info - PDL Biopharma, Inc. - ‘8-K’ for 2/7/05

SEC Info℠

Home

Help

Please Sign In

PDL Biopharma, Inc. – ‘8-K’ for 2/7/05

On: Monday, 2/7/05, at 5:29pm ET · For: 2/7/05 · Accession #: 1104659-5-4342 · File #: 0-19756

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/07/05  PDL Biopharma, Inc.               8-K:2,8,9   2/07/05    8:2.2M                                   Merrill Corp-MD/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     38K 
 2: EX-23.1     Consent of Experts or Counsel                       HTML      8K 
 3: EX-99.1     Miscellaneous Exhibit                               HTML     14K 
 4: EX-99.2     Miscellaneous Exhibit                               HTML     33K 
 5: EX-99.3     Miscellaneous Exhibit                               HTML    155K 
 6: EX-99.4     Miscellaneous Exhibit                               HTML     88K 
 7: EX-99.5     Miscellaneous Exhibit                               HTML    835K 
 8: EX-99.6     Miscellaneous Exhibit                               HTML    197K

Filing Submission 0001104659-05-004342 – SGML Text

Original SGML Text submitted by:	Toppan Merrill/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

PDL Biopharma, Inc. – ‘8-K’ for 2/7/05

On: Monday, 2/7/05, at 5:29pm ET · For: 2/7/05 · Accession #: 1104659-5-4342 · File #: 0-19756

Previous ‘8-K’: ‘8-K’ on 2/4/05 for 2/2/05 · Next: ‘8-K’ on 2/9/05 for 2/8/05 · Latest: ‘8-K’ on 12/14/20 for 12/11/20

Current Report — Form 8-KFiling Table of Contents

To view the SGML, please refresh this page.

Current Report — Form 8-K
Filing Table of Contents

To view the SGML, please refresh
this page.